Cormorant Asset Management, LP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$122,950,916
+43.5%
4,662,530
-6.4%
7.17%
+49.5%
Q2 2023$85,655,639
+113258.1%
4,979,979
+9.3%
4.80%
-3.6%
Q1 2023$75,562
+624.3%
4,557,414
+232.9%
4.98%
+612.9%
Q4 2022$10,433
-99.9%
1,369,179
-6.8%
0.70%
-31.6%
Q3 2022$14,604,000
+9.5%
1,469,1790.0%1.02%
+1.2%
Q2 2022$13,340,000
-16.2%
1,469,179
-6.4%
1.01%
-17.5%
Q1 2022$15,924,000
-42.8%
1,568,909
-6.0%
1.22%
-26.1%
Q4 2021$27,837,000
-66.4%
1,668,909
-5.7%
1.66%
-50.8%
Q3 2021$82,909,000
-27.7%
1,768,909
-6.0%
3.37%
-13.5%
Q2 2021$114,665,000
-14.2%
1,880,980
-13.3%
3.90%
+30.9%
Q1 2021$133,605,000
-17.1%
2,168,909
-4.3%
2.98%
-22.4%
Q4 2020$161,118,000
+89.5%
2,265,7620.0%3.83%
+17.3%
Q3 2020$85,011,000
+0.6%
2,265,762
-12.5%
3.27%
+1.4%
Q2 2020$84,485,000
-1.2%
2,590,762
-12.2%
3.22%
-18.9%
Q1 2020$85,550,000
-2.9%
2,950,000
+17.4%
3.98%
+13.1%
Q4 2019$88,076,000
+56.7%
2,512,865
-4.0%
3.52%
+2.7%
Q3 2019$56,199,000
-25.1%
2,617,566
-5.9%
3.42%
-20.6%
Q2 2019$75,000,0002,780,8854.31%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$100,609,51348.41%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$514,990,89915.50%
M28 Capital Management LP 304,700$5,051,9265.71%
Cormorant Asset Management, LP 4,557,414$75,5624.98%
Octagon Capital Advisors LP 1,338,160$22,186,6933.19%
Ikarian Capital, LLC 594,686$9,859,8942.24%
Affinity Asset Advisors, LLC 389,800$6,462,8842.13%
VIKING GLOBAL INVESTORS LP 26,620,991$441,376,0312.07%
Ikarian Capital, LLC 549,600$9,112,3682.07%
Affinity Asset Advisors, LLC 320,000$5,305,6001.75%
View complete list of BRIDGEBIO PHARMA INC shareholders